Zimbabwe has rejected a significant US health deal worth 367 million US dollars (272 million pounds) spanning five years due to the United States' insistence on sensitive data.
This move was revealed following a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa felt the arrangement was "skewed".
An official representative has since explained that the United States was requesting health data for research and profit but refused to share the resulting advantages from any future vaccines.
"We will now turn to the challenging and unfortunate process of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had provided more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for continued talks to reach a agreement suitable to both sides so the country's critical HIV treatment initiative can proceed.
Broader Context
This rejection comes after a comparable situation in neighbouring Kenya, where a high court suspended a related health funding agreement after concerns were filed about the security of citizens' medical information.
After returning to the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had managed assistance for the US government, but Trump claimed its spending was "inefficient" and his administration was seeking direct bilateral deals to enhance openness and accountability.
As per reports, 16 nations in Africa have so far agreed to these new agreements, representing over $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment through American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, without any equivalent assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"Effectively, our country would provide the basic resources for scientific discovery without any certainty that the end products would be available to our citizens if a future health crisis emerge."
National Interest and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining systems already established through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with future pandemics.
"This framework is intended to guarantee that when a nation provides its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage continued discussions with our US partners on how future co-operation might be arranged in a manner that honours the sovereignty and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but recommended that negotiations must proceed since much of the nation's HIV programmes were funded by international support.
"In cases where specific concerns exist, including those relating to data governance or implementation frameworks, these can often be resolved via detailed discussion and negotiated safeguards," it commented.
The halted deal emphasises the continuing debate between accepting crucial foreign assistance and protecting national sovereignty in an ever more data-driven world.